Información bibliográfica
GuíaWHO updated recommendations on HIV clinical management: recommendations for a public health approach
Año de publicación2025
Institución emisoraWorld Health Organization
Recomendación
Actualizada
Use of darunavir/ritonavir and other protease inhibitors in HIV treatment. Darunavir/ritonavir (DRV/r) is the preferred boosted protease inhibitor option for antiretroviral treatment.
Recomendado a favor
Fuerte
Certeza de la evidencia
Moderada